DOI QR코드

DOI QR Code

Ginsenoside Rg3이 Lipopolysaccharide에 의한 생쥐 뇌조직의 Cyclooxygenase-2 발현에 미치는 영향

Effect of Ginsenoside Rg3 on COX-2 Expression in Brain Tissue of Lipopolysaccharide-Treated Mice

  • 최원익 (경희대학교 동서의학대학원 한의과학전공) ;
  • 조용덕 (경희대학교 동서의학대학원 한의과학전공) ;
  • 이준석 (경희대학교 동서의학대학원 한의과학전공) ;
  • 신정원 (경희대학교 동서의학대학원 한의과학전공) ;
  • 김성준 (경희대학교 동서의학대학원 한의과학전공) ;
  • 손낙원 (경희대학교 동서의학대학원 한의과학전공)
  • Choi, Wonik (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Cho, Yong-Deok (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Lee, Joon-Seok (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Shin, Jung-Won (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Kim, Seong-Joon (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Sohn, Nak-Won (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
  • 투고 : 2012.09.10
  • 심사 : 2012.11.08
  • 발행 : 2012.11.30

초록

Objectives : Cyclooxygenase (COX) plays a central role in the inflammatory cascade by converting arachidonic acid into prostaglandin. COX-2 is typically induced by inflammatory stimuli in the majority of tissues, it is responsible for propagating the inflammatory response and thus, considered as the best target for anti-inflammatory drugs. The present study investigated the modulatory effect of ginsenoside Rg3, a principle active ingredient in Panax ginseng, on COX-2 expression in the brain tissue induced by systemic lipopolysaccharide (LPS) treatment in C57BL/6 mice. Methods : Because systemic LPS treatment induces COX-2 expression immediately in the brain, ginsenoside Rg3 was treated orally with doses of 10, 20, and 30 mg/kg at 1 hour before the LPS (3 mg/kg, i.p.) injection. At 4 hours after the LPS injection, COX-2 mRNA was measured by real-time polymerase chain reaction method, COX-2 protein levels were measured by Western blotting. In addition, COX-2 expressions in brain tissue were observed with immunohistochemistry and double immunofluoresence labeling. Results : Ginsenoside Rg3 (20 and 30 mg/kg) significantly attenuates up-regulation of COX-2 mRNA and protein expression in brain tissue at 4 hours after the LPS injection. Moreover, ginsenoside Rg3 (20 mg/kg) significantly reduced the number of COX-2 positive neurons in the cerebral cortex and amygdala. Conclusion : These results indicate that ginsenoside Rg3 plays a modulatory role in neuroinflammation through the inhibition of COX-2 expression in the brain and suggest that ginsenoside Rg3 and ginseng may be effective on neurodegenerative diseases caused by neuroinflammation.

키워드

참고문헌

  1. Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep. 2011 ; 28(3) : 467-95. https://doi.org/10.1039/c0np00057d
  2. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999 ; 58 : 1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  3. Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, Wang C, Liu K. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett. 2005 ; 374(2) : 92-97. https://doi.org/10.1016/j.neulet.2004.10.030
  4. Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS, Lee BH, Lee JH, Pyo MK, Lee SM, Chung JM, Kim S, Rhim H, Oh JW, Nah SY. Neuroprotective effects of ginsenoside Rg3 against homocysteine- induced excitotoxicity in rat hippocampus. Brain Res. 2007 ; 1136(1) : 190-9. https://doi.org/10.1016/j.brainres.2006.12.047
  5. Kim S, Kim T, Ahn K, Park WK, Nah SY, Rhim H. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun. 2004 ; 323(2) : 416-24. https://doi.org/10.1016/j.bbrc.2004.08.106
  6. Kim S, Nah SY, Rhim H. Neuroprotective effects of ginseng saponins against L-type Ca2+ channel-mediated cell death in rat cortical neurons. Biochem Biophys Res Commun. 2008 ; 365(3) : 399-405. https://doi.org/10.1016/j.bbrc.2007.10.048
  7. Tian J, Zhang S, Li G, Liu Z, Xu B. 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain. Phytother Res. 2009 ; 23(4) : 486-91. https://doi.org/10.1002/ptr.2653
  8. Joo SS, Yoo YM, Ahn BW, Nam SY, Kim YB, Hwang KW, Lee do I. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull. 2008 ; 31(7) : 1392-6. https://doi.org/10.1248/bpb.31.1392
  9. Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med. 2006 ; 72(7) : 627-33. https://doi.org/10.1055/s-2006-931563
  10. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol. 1999 ; 13(1) : 45-82. https://doi.org/10.1615/CritRevNeurobiol.v13.i1.30
  11. Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci. 2009 ; 30(4) : 174-81. https://doi.org/10.1016/j.tips.2009.01.002
  12. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004 ; 63(9) : 901-10. https://doi.org/10.1093/jnen/63.9.901
  13. Chen QJ, Zhang MZ, Wang LX. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol Biochem. 2010 ; 26(6) : 849-58. https://doi.org/10.1159/000323994
  14. Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res. 2009 ; 32(5) : 755-65. https://doi.org/10.1007/s12272-009-1515-4
  15. Bae EA, Han MJ, Shin YW, Kim DH. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol Pharm Bull. 2006 ; 29(9) : 1862-7. https://doi.org/10.1248/bpb.29.1862
  16. Kang KS, Kim HY, Yamabe N, Park JH, Yokozawa T. Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radic Res. 2007 ; 41(10) : 1181-8. https://doi.org/10.1080/10715760701581740
  17. Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2009 ; 23(3) : 309-17. https://doi.org/10.1016/j.bbi.2008.09.002
  18. Chung DW, Yoo KY, Hwang IK, Kim DW, Chung JY, Lee CH, Choi JH, Choi SY, Youn HY, Lee IS, Won MH. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell Mol Neurobiol. 2010 ; 30(4) : 531-41. https://doi.org/10.1007/s10571-009-9477-0
  19. Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med. 2010 ; 42(12) : 823-32. https://doi.org/10.3858/emm.2010.42.12.085
  20. Cao C, Matsumura K, Yamagata K, Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. 1995 ; 697(1-2) : 187-96. https://doi.org/10.1016/0006-8993(95)00839-I
  21. Aid S, Bosetti F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie. 2011 ; 93(1) : 46-51. https://doi.org/10.1016/j.biochi.2010.09.009
  22. Hinz B, Brune K. Cyclooxygenase-2-10 years later. J Pharm Exp Ther. 2002 ; 300 : 367-75. https://doi.org/10.1124/jpet.300.2.367
  23. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004 ; 63(9) : 901-10. https://doi.org/10.1093/jnen/63.9.901
  24. Wang H, Hitron IM, Iadecola C, Pickel VM. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cereb Cortex. 2005 ; 15(8) : 1250-60. https://doi.org/10.1093/cercor/bhi008
  25. Stefanovic B, Bosetti F, Silva AC. Modulatory role of cyclo- oxygenase-2 in cerebrovascular coupling. Neuroimage. 2006 ; 32(1) : 23-32. https://doi.org/10.1016/j.neuroimage.2006.03.014
  26. Hewett SJ, Bell SC, Hewett JA. Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther. 2006 ; 112(2) : 335-57. https://doi.org/10.1016/j.pharmthera.2005.04.011
  27. Lee EJ, Son GH, Chung S, Lee S, Kim J, Choi S, Kim K. Impairment of fear memory consolidation in maternally stressed male mouse offspring: evidence for nongenomic glucocorticoid action on the amygdala. J Neurosci. 2011 ; 31(19) : 7131-40. https://doi.org/10.1523/JNEUROSCI.4692-10.2011
  28. Tan H, Lauzon NM, Bishop SF, Chi N, Bechard M, Laviolette SR. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci. 2011 ; 31(14) : 5300-12. https://doi.org/10.1523/JNEUROSCI.4718-10.2011
  29. Fischborn SV, Soerensen J, Potschka H. Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice. Epilepsy Res. 2010 ; 91(1) : 57-65. https://doi.org/10.1016/j.eplepsyres.2010.06.012
  30. Vidensky S, Zhang Y, hand T, Goellner J, Shaffer A, Isakson P, Andreasson K. Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromolecular Med. 2003 ; 3(1) : 15-28. https://doi.org/10.1385/NMM:3:1:15
  31. Quan N, Whiteside M, Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 1998 ; 802(1-2) : 189-97. https://doi.org/10.1016/S0006-8993(98)00402-8